WalkAide Compared to Ankle-Foot Orthosis (AFO) in Stroke Patients

NCT01087957 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 495

Last updated 2014-05-13

Study results available
· View outcomes & findings →

Summary

To establish equivalence or incremental benefit to standard of care Ankle-Foot Orthosis (AFO) for patients with foot drop due to stroke, and to assess the functional improvement of ambulation and improved activities of daily living.

Conditions

Interventions

DEVICE

WalkAide

Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)

OTHER

Ankle-Foot Orthosis (AFO)

Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)

Sponsors & Collaborators

  • Innovative Neurotronics

    lead INDUSTRY

Principal Investigators

  • Francois Bethoux, M.D. · The Cleveland Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2012-02-29
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01087957 on ClinicalTrials.gov